Long non-coding RNA ACTA2-AS1 suppresses metastasis of papillary thyroid cancer via regulation of miR-4428/KLF9 axis. | Long non-coding RNA ACTA2-AS1 suppresses metastasis of papillary thyroid cancer via regulation of miR-4428/KLF9 axis. Wu S, Zhu J, Jiang T, Cui T, Zuo Q, Zheng G, Li G, Zhou J, Chen X., Free PMC Article | 01/16/2024 |
Long Noncoding RNA ACTA2-AS1 Inhibits Cell Growth and Facilitates Apoptosis in Gastric Cancer by Binding with miR-6720-5p to Regulate ESRRB. | Long Noncoding RNA ACTA2-AS1 Inhibits Cell Growth and Facilitates Apoptosis in Gastric Cancer by Binding with miR-6720-5p to Regulate ESRRB. Hu Z, Chen Z, Jiang W, Fang D, Peng P, Yao S, Luo M, Wang L, Sun Z, Wang W, Wang X, Mao H, Ai F, Zhou P. | 11/28/2023 |
lncRNA ACTA2-AS1 predicts malignancy and poor prognosis of triple-negative breast cancer and regulates tumor progression via modulating miR-532-5p. | lncRNA ACTA2-AS1 predicts malignancy and poor prognosis of triple-negative breast cancer and regulates tumor progression via modulating miR-532-5p. Peng Y, Huang X, Wang H., Free PMC Article | 08/6/2022 |
Overexpression of long non-coding RNA ACTA2-AS1 inhibits the viability, proliferation, migration and invasion of colorectal cancer cells. | Overexpression of long non-coding RNA ACTA2-AS1 inhibits the viability, proliferation, migration and invasion of colorectal cancer cells. Wu X, Pang Q, Zhi F, Mao X, Hu Y. | 06/11/2022 |
Knockdown of lncRNA ACTA2-AS1 reverses cisplatin resistance of ovarian cancer cells via inhibition of miR-378a-3p-regulated Wnt5a. | Knockdown of lncRNA ACTA2-AS1 reverses cisplatin resistance of ovarian cancer cells via inhibition of miR-378a-3p-regulated Wnt5a. Lin C, Zheng M, Yang Y, Chen Y, Zhang X, Zhu L, Zhang H., Free PMC Article | 04/30/2022 |
Long non-coding RNA ACTA2-AS1 inhibits the cisplatin resistance of non-small cell lung cancer cells through inhibiting autophagy by suppressing TSC2. | Long non-coding RNA ACTA2-AS1 inhibits the cisplatin resistance of non-small cell lung cancer cells through inhibiting autophagy by suppressing TSC2. Liu X, Zhang X, Du S., Free PMC Article | 04/23/2022 |
ACTA2-AS1 suppresses lung adenocarcinoma progression via sequestering miR-378a-3p and miR-4428 to elevate SOX7 expression. | ACTA2-AS1 suppresses lung adenocarcinoma progression via sequestering miR-378a-3p and miR-4428 to elevate SOX7 expression. Ying K, Wang L, Long G, Lian C, Chen Z, Lin W. | 07/10/2021 |
Enhanced expression of lncRNA ZXF1 promotes cisplatin resistance in lung cancer cell via MAPK axis. | Enhanced expression of lncRNA ZXF1 promotes cisplatin resistance in lung cancer cell via MAPK axis. Yu T, Bai W, Su Y, Wang Y, Wang M, Ling C. | 12/19/2020 |
Downregulation of long non-coding RNA ZXF1 restricts cell survival by targeting miR-634-GRB2 in lung adenocarcinoma. | Downregulation of long non-coding RNA ZXF1 restricts cell survival by targeting miR-634-GRB2 in lung adenocarcinoma. Ren X, Xu N, Zhang Y, Wang T. | 11/21/2020 |
Downregulation of ACTA2AS1:4 affects a number of key mechanisms involved in liver cancer progression. These data may be important for the future of liver cancer diagnosis and subsequent treatments. | Knockdown of ACTA2‑AS1 promotes liver cancer cell proliferation, migration and invasion. Zhou RJ, Lv HZ. | 05/25/2019 |
mRNAs were differentially expressed in the HepG2 cell line after the down-regulation of long noncoding rna-UC001kfo. | Differential expression of genes in HepG2 cells caused by UC001kfo RNAi as shown by RNA-seq. Pan YF, Su T, Chen LD, Qin T. | 05/5/2018 |